|
Re: Resverlogix Announces Annual and Special Meeting of Shareholders
|
2
|
Resverlogix Corp.
|
Aug 22, 2019 07:14PM
|
|
Re: Resverlogix Announces Third Positive Recommendation From DSMB For Phase 3 BETonMACE
|
2
|
Resverlogix Corp.
|
Mar 17, 2017 08:47AM
|
|
AACR 2018
|
2
|
Zenith Epigenetics
|
Jan 18, 2018 04:07PM
|
|
Zenith Epigenetics Announces Clinical Advancement of ZEN-3694
|
2
|
Zenith Epigenetics
|
Dec 19, 2019 09:36AM
|
|
Re: ERA-EDTA posters
|
2
|
Resverlogix Corp.
|
May 24, 2018 08:46AM
|
|
Re: 2 new upcoming presentations
|
2
|
Resverlogix Corp.
|
May 04, 2020 07:50AM
|
|
RVX in the next 7 weeks (revised)
|
2
|
Resverlogix Corp.
|
Aug 13, 2015 01:38PM
|
|
Re: Good News for Zenith
|
2
|
Zenith Epigenetics
|
Dec 19, 2019 09:38AM
|
|
Re: A lot of expectations...???
|
2
|
Resverlogix Corp.
|
Dec 16, 2016 11:46AM
|
|
Re: Dulaglutide
|
2
|
Resverlogix Corp.
|
Feb 25, 2020 12:48PM
|
|
Re: What else can RVX treat that we don’t know about yet?
|
2
|
Resverlogix Corp.
|
Mar 31, 2019 07:40AM
|
|
Re: Now following.
|
2
|
BIOASIS TECHNOLOGIES INC
|
May 08, 2019 10:47AM
|
|
Re: Could there be another shoe waiting to drop?
|
2
|
Resverlogix Corp.
|
May 19, 2019 09:04PM
|
|
Re: Now published: Rationale, design, and baseline characteristics of the BETonMACE trial
|
2
|
Resverlogix Corp.
|
Sep 16, 2019 03:05PM
|
|
Now the webcast is up
|
2
|
Resverlogix Corp.
|
Mar 11, 2019 01:24PM
|
|
Re: A few comments
|
2
|
Resverlogix Corp.
|
Jan 12, 2017 02:10PM
|
|
Re: Welcome to the Resverlogix Lunch Counter, January special is the nothingburger...
|
2
|
Resverlogix Corp.
|
Jan 23, 2019 05:03PM
|
|
Re: Now the webcast is up
|
2
|
Resverlogix Corp.
|
Mar 11, 2019 01:31PM
|
|
Recent changes
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 31, 2019 08:19AM
|
|
Re: Bioasis Corporate Presentation Slide Deck from April 2019
|
2
|
BIOASIS TECHNOLOGIES INC
|
Apr 20, 2019 12:47PM
|
